nana extract and homoharringtonine inhibited GPR68 activity and that the use of these inhibitors ameliorated CKD-induced cardiac inflammation, fibrosis, and dysfunction in a murine model [174]. The gene discussed is GPR68; the disease is chronic kidney disease.